All medicines may cause side effects, but many people have no, or minor, side effects. Pantoprazole sodium for injection contains edetate disodium the salt form of EDTA a chelator of metal ions including zinc. Therefore, zinc supplementation should be considered in patients treated with pantoprazole sodium for injection who are prone to zinc deficiency. Caution should be used when other EDTA containing products are also co-administered intravenously. CYP3A4 substrates metoprolol a CYP2D6 substrate diclofenac, naproxen and piroxicam CYP2C9 substrates and theophylline a CYP1A2 substrate in healthy subjects, the pharmacokinetics of pantoprazole were not significantly altered. canada oxybutynin use
Always take this medicine exactly as your doctor or pharmacist has told you. In most patients, treatment of hypomagnesemia required magnesium replacement and discontinuation of the PPI. Pantoprazole delayed-release tablets may cause drowsiness or dizziness. These effects may be worse if you take it with alcohol or certain medicines. Use pantoprazole delayed-release tablets with caution. Inhibition of gastric acid output and the percent inhibition of stimulated acid output in response to pantoprazole sodium for injection may be higher after repeated doses. Midazolam HCl has been shown to be incompatible with Y-site administration of pantoprazole sodium for injection. Pantoprazole sodium for injection may not be compatible with products containing zinc. When pantoprazole sodium for injection is administered through a Y-site, immediately stop use if precipitation or discoloration occurs.
The reconstituted solution may be stored for up to 24 hours at room temperature prior to intravenous infusion and does not need to be protected from light. Pantoprazole sodium for injection should be administered intravenously over a period of at least 2 minutes. Spanish adolescents: Further evidence. Appropriate studies on the relationship of age to the effects of pantoprazole have not been performed in the pediatric population. Safety and efficacy have not been established. Pantoprazole may stop these and other medicines from working properly.
Pantoprazole doses ³50 mg per kg caused a slight increased frequency of hepatocellular tumor in rats, while in female mice dose of 150 mg per kg also resulted in an increased frequency. However, in both animals, the incidence of hepatocellular tumor was within historical control ranges for the strains tested. The tumors were characterized as late-appearing and primarily benign. Exposure to these unusually large doses for prolonged periods is associated with enzyme induction in rodents, leading to hepatomegaly and centrilobular hypertrophy. These findings not associated with the lower clinical doses and are apparently not applicable to human exposure.
Although serum half-life values increased to 7 to 9 hours and AUC values increased by 5- to 7-fold in hepatic-impaired patients, these increases were no greater than those observed in CYP2C19 poor metabolizers, where no dosage adjustment is warranted. These pharmacokinetic changes in hepatic-impaired patients result in minimal drug accumulation following once-daily, multiple-dose administration. No dosage adjustment is needed in patients with mild to severe hepatic impairment. Study 1 was a multicenter, double-blind, placebo-controlled, study of the pharmacodynamic effects of pantoprazole sodium for injection and oral pantoprazole sodium. Do not take a double dose to make up for a forgotten dose. Take your next normal dose at the usual time. Keep this leaflet. You may need to read it again. F96022 in healthy volunteers.
In one study of gastric pH in healthy subjects, pantoprazole was administered orally 40 mg enteric coated tablets or intravenously 40 mg once daily for 5 days and pH was measured for 24 hours following the fifth dose. Swallow tablets whole. Do not break, chew, or crush. During 6 days of repeated administration of pantoprazole sodium for injection in patients with Zollinger-Ellison Syndrome, consistent changes of serum gastrin concentrations from baseline were not observed. It is not known whether pantoprazole is distributed into human breast milk. See USP Controlled Room Temperature. After first opening of the container, the product should be used within 3 months. Caucasians and African-Americans and 17% to 23% of Asians are poor metabolizers. For adult patients who are CYP2C19 poor metabolizers, no dosage adjustment is needed. Store pantoprazole delayed-release tablets at room temperature, between 68 and 77 degrees F 20 and 25 degrees C. Store away from heat, moisture, and light. Do not store in the bathroom. Keep pantoprazole delayed-release tablets out of the reach of children and away from pets. What are the side effects of pantoprazole? Pantoprazole delayed-release tablets comes with an extra patient information sheet called a Medication Guide. Read it carefully. Read it again each time you get pantoprazole delayed-release tablets refilled. European Union EU called Pantozol. What is Pantozol Control used for? Because pantoprazole has been in use for many years, the applicant presented data from the scientific literature. The applicant also presented information from two main studies looking at the effects of pantoprazole 20 mg in a total of 563 adults who had symptoms of acid reflux, including at least one episode of heartburn in the three days before the studies began. The first study compared pantoprazole with placebo a dummy treatment in 219 adults, and the second compared it with ranitidine another medicine used to treat acid reflux symptoms in 344 adults. The main measure of effectiveness was the number of patients with symptoms of heartburn over the first two weeks of treatment. What benefit has Pantozol Control shown during the studies? Pue MA, Laroche J, Meineke I et al: Pharmacokinetics of pantoprazole following single intravenous and oral administration to healthy male subjects. Pantoprazole is indicated for the prevention of relapse in patients with reflux esophagitis. etodolac
Important: The opinions expressed in WebMD User-generated content areas like communities, reviews, ratings, blogs, or WebMD Answers are solely those of the User, who may or may not have medical or scientific training. These opinions do not represent the opinions of WebMD. User-generated content areas are not reviewed by a WebMD physician or any member of the WebMD editorial staff for accuracy, balance, objectivity, or any other reason except for compliance with our Terms and Conditions. In another placebo-controlled, 7-day study of 40 mg intravenous or oral pantoprazole in patients with GERD and a history of erosive esophagitis, the mean serum gastrin concentration increased approximately 50% from baseline and as compared with placebo, but remained within the normal range. Approximately 3% of Caucasians and African-Americans and between 17% and 23% of Asians have deficiency of the CYP2C19 hepatic enzyme system, resulting in slow metabolism. Although certain pharmacokinetic values such as half-life and serum concentrations of pantoprazole will be enhanced in these patients, no specific dose adjustments are recommended, and no differences in safety or efficacy are apparent. Although no significant drug-drug interactions have been observed in clinical studies, the potential for significant drug-drug interactions with more than once daily dosing with high doses of pantoprazole has not been studied in poor metabolizers or individuals who are hepatically impaired. Dosage adjustment of such drugs is not necessary when they are co-administered with pantoprazole. In other in vivo studies, digoxin, ethanol, glyburide, antipyrine, caffeine, metronidazole, and amoxicillin had no clinically relevant interactions with pantoprazole. Pantoprazole and its metabolites are excreted in the milk of rats. Pantoprazole excretion in human milk has been detected in a study of a single nursing mother after a single 40 mg oral dose. The clinical relevance of this finding is not known. Many drugs which are excreted in human milk have a potential for serious adverse reactions in nursing infants. Based on the potential for tumorigenicity shown for pantoprazole in rodent carcinogenicity studies, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the benefit of the drug to the mother. Pantoprazole as a long-term treatment. PREGNANCY and BREAST-FEEDING: If you become pregnant, contact your doctor. You will need to discuss the benefits and risks of using pantoprazole delayed-release tablets while you are pregnant. Pantoprazole delayed-release tablets are found in breast milk. Do not breast-feed while taking pantoprazole delayed-release tablets. US FDA pregnancy category B: Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women. Canada JR ed: USP Dictionary of USAN and International Drug Names. The United States Pharmacopeial Convention, Inc. Acid secretion decreased by 100% after 2 hours of 80 mg intravenous administration. If you miss a dose of pantoprazole delayed-release tablets, take it as soon as possible. If it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not take 2 doses at once. If you suffer from severe liver problems, you should not take more than one 20 mg tablet a day. There was a 78% reduction in the C max and a 45% reduction in the AUC of MPA in patients receiving both pantoprazole and MMF. purchase now cheapest propecia uk propecia
There have been postmarketing reports of increased INR and prothrombin time in patients receiving proton pump inhibitors, including pantoprazole, and warfarin concomitantly. Increases in INR and prothrombin time may lead to abnormal bleeding and even death. Patients treated with proton pump inhibitors and warfarin concomitantly should be monitored for increases in INR and prothrombin time. Rockville, MD, 1998. p 548. Patients should be instructed to inform their healthcare provider if they develop any unusual symptom, or if any known symptom persists or worsens. Animal models have failed to revealed evidence of impaired fertility or fetal harm. There are no controlled data in human pregnancy. Pantoprazole delayed-release tablets are to be used only by the patient for whom it is prescribed. Do not share it with other people. The active substance is pantoprazole. Container: Keep the container tightly closed in order to protect from moisture. If you have severe liver problems. Please tell your doctor if you have ever had problems with your liver. In a clinical pharmacology study, pantoprazole 40 mg given orally once daily for 2 weeks had no effect on the levels of the following hormones: cortisol, testosterone, triiodothyronine T 3 thyroxine T 4 thyroid-stimulating hormone, thyronine-binding protein, parathyroid hormone, insulin, glucagon, renin, aldosterone, follicle-stimulating hormone, luteinizing hormone, prolactin and growth hormone. provera tablet price philippines
Inside Science: “Time of Day Could Impact Athletes' Performance Peak. Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and Drugs. Pantoprazole sodium for injection 40 mg once daily does not raise gastric pH to levels sufficient to contribute to the treatment of such life-threatening conditions. Methotrexate a chemotherapy medicine used in high doses to treat cancer. An increase in liver enzymes. Diabetes Forecast: “Does It Matter When You Exercise? Byk- Canada. In: Krogh CME ed: Compendium of Pharmaceuticals and Specialties, 34th ed. Canadian Pharmaceutical Association, Ottawa, Ontario, Canada, 1999. Severe allergic reactions rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, hands, eyes, throat, or tongue; unusual hoarseness; bloody or watery stools; bone pain; chest pain; fast or irregular heartbeat; fever, chills, or sore throat; red, swollen, blistered, or peeling skin; severe or persistent diarrhea or stomach pain; severe or persistent nausea or vomiting; stomach cramps; symptoms of kidney problems eg, not able to pass urine, change in the amount of urine produced, blood in the urine, a big weight gain; symptoms of liver problems eg, yellowing of the skin or eyes, dark urine, pale stools, nausea, loss of appetite, unusual tiredness; unexplained weight loss; unusual bruising or bleeding; vision changes. The FDA approved Pantoprazole in February 2000. Swallow pantoprazole delayed-release tablets whole. Do not break, crush, or chew before swallowing. You should report any new and exceptional symptoms and circumstances whenever you see your doctor. HGPRT forward mutation assay for mutagenic effects. Equivocal results were observed in the in vivo rat liver DNA covalent binding assay. Food and Drug Administration. WebMD does not endorse any specific product, service, or treatment. Do not consider WebMD User-generated content as medical advice. Never delay or disregard seeking professional medical advice from your doctor or other qualified healthcare provider because of something you have read on WebMD. You should always speak with your doctor before you start, stop, or change any prescribed part of your care plan or treatment. WebMD understands that reading individual, real-life experiences can be a helpful resource, but it is never a substitute for professional medical advice, diagnosis, or treatment from a qualified health care provider. If you think you may have a medical emergency, call your doctor or dial 911 immediately. Oral, 20 mg once a day in the morning. Dose can be increased to 40 mg once a day in the morning in the case of recurrence. Parenteral routes of administration other than intravenous are not recommended. Adequate and well-controlled studies in humans have not been done. msis.info suprax
Division of Sleep Medicine at Harvard Medical School: “Sleep, Learning, and Memory. American Academy of Dermatology: “How to apply sunscreen. Pantoprazole delayed-release tablets are indicated for the short-term up to 8 weeks treatment of heartburn and other symptoms associated with GERD. Pantoprazole for injection is indicated for the short-term 7 to 10 days treatment of GERD in patients who are unable to continue taking pantoprazole delayed-release tablets. Pantoprazole for injection is not indicated for initial treatment of GERD. Pantoprazole 40 mg tablets instead, one a day. After healing, you can reduce the dose back again to one tablet 20 mg a day. No dose adjustment of clopidogrel is necessary when administered with an approved dose of pantoprazole sodium. Hematologic: leukopenia reported in ex-U. Blister pack: Store in the original package in order to protect from moisture. Take pantoprazole delayed-release tablets by mouth with or without food. Product Information: Pantoloc, pantoprazole. Solvay Pharma, Ontario, Canada. Pantoprazole peak serum concentration C max and area under the serum concentration-time curve AUC increase in a manner proportional to intravenous doses from 10 mg to 80 mg. Pantoprazole does not accumulate and its pharmacokinetics are unaltered with multiple daily dosing. Following the administration of pantoprazole sodium for injection, the serum concentration of pantoprazole declines biexponentially with a terminal elimination half-life of approximately one hour. These measures will help protect the environment. Tablets may be taken before, during, or following the morning meal. Neither food nor antacids altered the bioavailability of pantoprazole. Do not throw away any medicines via wastewater or household waste. Keep this medicine out of the sight and reach of children. CDAD. A diagnosis of CDAD should be considered for patients taking PPIs who develop diarrhea that does not improve. The FDA is working with manufacturers to include information about the increased risk of CDAD with use of PPIs in the drug labels. FDA is also reviewing the risk of CDAD in users of histamine H2 receptor blockers. Published observational studies suggest that PPI therapy like pantoprazole sodium may be associated with an increased risk of Clostridium difficile associated diarrhea, especially in hospitalized patients.
Pantoprazole, although metabolized by hepatic cytochrome P 450 systems, does not appear to either inhibit or induce cytochrome P 450 enzyme activity. To date, no clinically significant interactions have been noted for such commonly used drugs as diazepam, phenytoin, nifedipine, theophylline, digoxin, warfarin, or oral contraceptives. ATPase enzyme system at the secretory surface of the gastric parietal cell. This effect leads to inhibition of both basal and stimulated gastric acid secretion irrespective of the stimulus. Is pantoprazole available as a generic drug? Pantoprazole delayed-release tablets may increase the risk of hip, wrist, and spine fractures in patients with weak bones osteoporosis. The risk may be greater if you use pantoprazole delayed-release tablets in high doses or for longer than a year, or if you are older than 50 years old. Contact your doctor if you have any questions about this information. Pantoprazole is a proton pump inhibitor. It accumulates in the acidic compartment of parietal cells and is converted to the active form, a sulfanilamide, which binds to hydrogen-potassium-ATP-ase at the secretory surface of gastric parietal cells. Inhibition of hydrogen-potassium-ATP-ase blocks the final step of gastric acid production, leading to inhibition of both basal and stimulated acid secretion. The duration of inhibition of acid secretion does not correlate with the much shorter elimination half-life of pantoprazole. Pantoprazole, in combination with clarithromycin and either amoxicillin or metronidazole, is indicated for treatment of patients with an active duodenal ulcer who are H. pylori positive. Patients should use the lowest dose and shortest duration of PPI therapy appropriate to the condition being treated. Gas; headache; joint pain; mild diarrhea or stomach pain; nausea; symptoms of upper respiratory tract infection eg, cough, runny or stuffy nose, sneezing in children; vomiting. Pantoprazole delayed-release tablets may interfere with certain lab tests. Be sure your doctor and lab personnel know you are taking pantoprazole delayed-release tablets. trihexyphenidyl
Hypomagnesemia, symptomatic and asymptomatic, has been reported rarely in patients treated with PPIs for at least three months, and in most cases after a year of therapy. Some MEDICINES MAY INTERACT with pantoprazole delayed-release tablets. Sodium Chloride Injection, USP, or Lactated Ringer's Injection, USP. Since pantoprazole is acid-labile, it is administered as an enteric-coated tablet to prevent gastric decomposition and to increase bioavailability. Tablets should be swallowed whole, and not split, chewed, or crushed. If your symptoms do not improve or if they become worse, check with your doctor. Transition from oral to intravenous and from intravenous to oral formulations of gastric acid inhibitors should be performed in such a manner to ensure continuity of effect of suppression of acid secretion. Patients with Zollinger-Ellison Syndrome may be vulnerable to serious clinical complications of increased acid production even after a short period of loss of effective inhibition. Warfarin and phenprocoumon, which affect the thickening, or thinning of the blood. You may need further checks. See Usual adult dose. Pantoprazole, by increasing gastric pH, has the potential to affect the bioavailability of any medication for which absorption is pH-dependent. Also, pantoprazole may prevent the degradation of acid-labile drugs. F. Protect from freezing and from light. cost olmesartan price
The stability of the compound in aqueous solution is pH-dependent. Due to extensive protein binding, pantoprazole is not readily dialyzable. Use pantoprazole delayed-release tablets with caution in the ELDERLY; they may be more sensitive to its effects, especially hip, wrist, and spine fractures. This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. Oral, 40 mg per day for up to two weeks. What is Pantozol Control? Atazanavir used to treat HIV-infection. Use pantoprazole delayed-release tablets as directed by your doctor. Check the label on the medicine for exact dosing instructions. Pantoprazole delayed-release tablets may increase the risk of a serious form of diarrhea. Contact your doctor right away if stomach pain or cramps, severe or persistent diarrhea, or bloody or watery stools occur. Discuss any questions or concerns with your doctor. ATPase results in a duration of antisecretory effect that persists longer than 24 hours for all doses tested 20 mg to 120 mg. Why has Pantozol Control been approved? AUC and elimination half-life values were similar to those observed in younger subjects. No dosage adjustment is recommended for elderly patients. buy ceclor with mastercard
Limited human overdose data available with any proton pump inhibitors. Best Time of Day to Nap? Pantoprazole-containing medicines have been available in the European Union EU since 1994. The reference medicine, Pantozol, is only available with a prescription. It is used for long-term treatments and is also used to treat a wider range of gastrointestinal diseases conditions affecting the gut than Pantozol Control. How has Pantozol Control been studied? If you have any further questions, ask your doctor or pharmacist. The recommended adult dose is 40 mg pantoprazole given once daily by intravenous infusion for 7 to 10 days. Safety and effectiveness of pantoprazole sodium for injection in pediatric patients have not been established. When pantoprazole is taken with food, the time to peak concentration is variable and may be significantly increased. Hurlbut KM Eds: POISINDEXR System. MICROMEDEX, Inc. Contact your doctor if you have any symptoms of a bleeding ulcer, such as black, tarry stools or vomit that looks like coffee grounds, or if you experience throat pain, chest pain, severe stomach pain, or trouble swallowing. There was also no interaction with concomitantly administered antacids. For Y-site administration, the in-line filter should be positioned below the Y-site that is closest to the patient. No gender-related differences in the safety profile of intravenous pantoprazole were seen in international trials involving 166 men and 120 women with erosive esophagitis associated with GERD. Pantoprazole delayed-release tablets should be used with caution in Asian patients; the risk of side effects may be increased in these patients. The dosage of pantoprazole sodium for injection in patients with pathological hypersecretory conditions including Zollinger-Ellison Syndrome varies with individual patients. The recommended adult dosage is 80 mg intravenously every 12 hours. The frequency of dosing can be adjusted to individual patient needs based on acid output measurements. allopurinol
Co-administration of pantoprazole in healthy subjects and in transplant patients receiving MMF has been reported to reduce the exposure to the active metabolite, mycophenolic acid MPA possibly due to a decrease in MMF solubility at an increased gastric pH. The clinical relevance of reduced MPA exposure on organ rejection has not been established in transplant patients receiving pantoprazole sodium for injection and MMF. If you have any questions about pantoprazole delayed-release tablets, please talk with your doctor, pharmacist, or other health care provider. Cardiac monitoring and blood pressure evaluation with significant overdose. Monitor fluid status and electrolytes with prolonged vomiting. Following oral or intravenous administration: 1 hour. This medicine has been prescribed for you only. Do not pass it on to others. Serious adverse events include tetany, arrhythmias, and seizures. Adverse events seen in spontaneous reports of overdose generally reflect the known safety profile of pantoprazole. Significantly different from pantoprazole sodium for injection. Ringer's injection before and after administration of pantoprazole. Rapidly absorbed. However, absorption may be delayed up to 2 hours or more if pantoprazole is taken with food.
purchase pantozol online payment europe, pantozol online 24 hours, purchase generic pantozol payment canada, generic pantozol us pharmacy, generic medicine for pantozol, pantozol shop in sydney, pantozol canada buy online, pantozol buy australia, pantozol can i purchase visa, pantozol tab price, purchase pantozol europe, alternative pills for pantozol, pantozol per month, generic pantozol buy online payment, pharmacy pantozol uk, store pantozol cost, generic pantozol buy shopping australia, shop pantozol information, purchase pantozol price, cheap pantozol starter pack, pantozol mail order pharmacy otc, cheap pantozol order mastercard otc, orlistat pantozol, shop pantozol dose, shoppers drug mart pantozol price, cheap pantozol uk, buy pantozol nedir, brand pantozol spc, pantozol canada price blog, generic equivalent pantozol 40 mg tablets, purchase cheap pantozol payment, money order pantozol online pharmacy, order now cheapest pantozol shopping, cheap pantozol level, buy generic pantozol online, order pantozol mastercard otc, cheap pantozol purchase store europe, pantozol online uk boots, pantozol printable discount coupons, generic substitute pantozol, pantozol retail cost, price pantozol contraindicaciones, pantozol bangladesh shop, pantozol buy online pharmacy uk, price pantozol at cvs pharmacy, purchase cheap pantozol pharmacy, pantozol pills order online pharmacy, pantozol discount code, cheapest pantozol order shopping australia, where can i order pantozol, pantozol tablet price philippines, cost pantozol price, pantozol generic brand side effects, pantozol generic price, canada pantozol use, buy pantozol with mastercard, purchase now cheapest pantozol uk
In patients with severe renal impairment, pharmacokinetic parameters for pantoprazole were similar to those of healthy subjects. No dosage adjustment is necessary in patients with renal impairment or in patients undergoing hemodialysis. GPT mammalian cell-forward gene mutation assay, the in vitro thymidine kinase mutation test with mouse lymphoma L5178Y cells, and the in vivo rat bone marrow cell chromosomal aberration assay. Several published observational studies suggest that proton pump inhibitor PPI therapy may be associated with an increased risk for osteoporosis-related fractures of the hip, wrist, or spine. The risk of fracture was increased in patients who received high-dose, defined as multiple daily doses, and long-term PPI therapy a year or longer. Patients should use the lowest dose and shortest duration of PPI therapy appropriate to the condition being treated. ziprasidone
Pantoprazole is not removed by hemodialysis. In case of overdose, treatment should be symptomatic and supportive. Pantozol Control is used for the short-term treatment of the symptoms of acid reflux in adults. Acid reflux is when acid produced in the stomach escapes into the gullet, causing heartburn and acid regurgitation acid flowing up into the mouth. By reporting side effects you can help provide more information on the safety of this medicine. The CHMP noted that pantoprazole 20 mg was effective in the short-term treatment of reflux symptoms and that there is a long safety experience with the medicine as a prescription medicine. It was also of the opinion that, based on the experience of the use of pantoprazole, the availability of Pantozol Control without medical supervision is appropriate. pyrantel generic price
If you have any further questions on the use of this medicine, ask your doctor or pharmacist. This prevents the active substance from being destroyed by the acid in the stomach. Dialysis removes insignificant amounts of pantoprazole. Pantoprazole is a selective “proton pump inhibitor”, a medicine which reduces the amount of acid produced in your stomach. Clopidogrel: Clopidogrel is metabolized to its active metabolite in part by CYP2C19. In a crossover clinical study, 66 healthy subjects were administered clopidogrel 300 mg loading dose followed by 75 mg per day alone and with pantoprazole 80 mg at the same time as clopidogrel for 5 days. On Day 5, the mean AUC of the active metabolite of clopidogrel was reduced by approximately 14% geometric mean ratio was 86%, with 90% CI of 79 to 93% when pantoprazole was coadministered with clopidogrel as compared to clopidogrel administered alone. Pharmacodynamic parameters were also measured and demonstrated that the change in inhibition of platelet aggregation induced by 5 µM ADP was correlated with the change in the exposure to clopidogrel active metabolite.
Do not stop taking these tablets without first talking to your doctor or pharmacist. Treatment with pantoprazole should be discontinued as soon as the patient is able to resume taking pantoprazole delayed-release tablets. Stevens-Johnson-Syndrome, Lyell-Syndrome, Erythema multiforme and sensitivity to light. About Memory: “Time of day effects in immediate and delayed memory. The magnitude and time course for inhibition of pentagastrin-stimulated acid output PSAO by single doses 20 to 120 mg of pantoprazole sodium for injection were assessed in a single-dose, open-label, placebo-controlled, dose-response study.